Published online before print May 21, 2009

This Article Full Text Full Text (PDF) All Versions of this Article: jmoldx.2009.090047v1 11/4/279    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Potter, N. T. Search for Related Content PubMed PubMed Citation Articles by Potter, N. T. Related Collections Related Article

Journal of Molecular Diagnostics 2009, Vol. 11, No. 4
Copyright © 2009 American Society for Investigative Pathology & Association for Molecular Pathology
DOI: 10.2353/jmoldx.2009.090047

Commentary

You Can Build It ... But Will They Come?

The Potential "Expansion" of Testing Methodologies for Fragile X Syndrome

From Molecular Pathology Laboratory Network, Inc., Maryville, Tennessee and the Department of Pathology, University of Tennessee Medical Center, Knoxville, Tennessee

This Commentary highlights a brief technical report by Iwashi and colleagues (J Mol Diagn 11: JMD08–0118) that describes an enhancement to an antibody-based ELISA assay for the detection of the FMR1 protein (FMRP) in peripheral blood.

Related Article

A Quantitative ELISA Assay for the Fragile X Mental Retardation 1 Protein

Christine Iwahashi, Flora Tassone, Randi J. Hagerman, Dag Yasui, George Parrott, Danh Nguyen, Greg Mayeur, and Paul J. Hagerman
J. Mol. Diagn. 2009 11: 281-289. [Abstract] [Full Text] [PDF]